Product NDC: | 63739-493 |
Proprietary Name: | Fluoxetine |
Non Proprietary Name: | Fluoxetine Capsules |
Active Ingredient(s): | 20 mg/1 & nbsp; Fluoxetine Capsules |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-493 |
Labeler Name: | McKesson Packaging Services Business Unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090223 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101118 |
Package NDC: | 63739-493-40 |
Package Description: | 100 CAPSULE in 1 BOTTLE (63739-493-40) |
NDC Code | 63739-493-40 |
Proprietary Name | Fluoxetine |
Package Description | 100 CAPSULE in 1 BOTTLE (63739-493-40) |
Product NDC | 63739-493 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fluoxetine Capsules |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20101118 |
Marketing Category Name | ANDA |
Labeler Name | McKesson Packaging Services Business Unit of McKesson Corporation |
Substance Name | FLUOXETINE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |